Excision repair cross-complementation group 1 (ERCC1) status and lung cancer outcomes: a meta-analysis of published studies and recommendations.

par Richard A Hubner, Richard D Riley, Lucinda J Billingham, Sanjay Popat
Publié 2011

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.

par Richard D Riley, Jill A Hayden, Ewout W Steyerberg, Karel G M Moons, Keith Abrams, Panayiotis A Kyzas, Núria Malats, Andrew Briggs, Sara Schroter, Douglas G Altman, Harry Hemingway, PROGRESS Group
Publié 2013

Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols.

par George Peat, Richard D Riley, Peter Croft, Katherine I Morley, Panayiotis A Kyzas, Karel G M Moons, Pablo Perel, Ewout W Steyerberg, Sara Schroter, Douglas G Altman, Harry Hemingway, PROGRESS Group
Publié 2014

Case-finding and improving patient outcomes for chronic obstructive pulmonary disease in primary care: the BLISS research programme including cluster RCT

par Peymané Adab, Rachel E Jordan, David Fitzmaurice, Jon G Ayres, KK Cheng, Brendan G Cooper, Amanda Daley, Andrew Dickens, Alexandra Enocson, Sheila Greenfield, Shamil Haroon, Kate Jolly, Sue Jowett, Tosin Lambe, James Martin, Martin R Miller, Kiran Rai, Richard D Riley, Steve Sadhra, Alice Sitch, Stanley Siebert, Robert A Stockley, Alice Turner
Publié 2021